Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What common side effects does omeprazole have in children?How does heavy alcohol use affect scar healing?Does lipitor's protein binding change with kidney function decline?Are there any dietary considerations with lipitor?What's the link between alcohol and antibiotic recovery?
See the DrugPatentWatch profile for cosentyx
How much Cosentyx is given for psoriasis? Cosentyx contains secukinumab. For adults with plaque psoriasis, the standard dose is 300 mg. This is given as two 150 mg injections under the skin at the same time. What happens after the first injection? The 300 mg dose is repeated once a week for the first five weeks. After that, it switches to once a month. Why is the dose kept at 300 mg? Clinical studies showed that 300 mg works better than 150 mg for skin clearance. Most patients keep using 300 mg unless they have side effects or the doctor sees a reason to lower it. How does this dose compare with other conditions? For psoriatic arthritis or ankylosing spondylitis, many patients start with 150 mg per injection. Only some cases of psoriatic arthritis erleben a switch to 300 mg when they also have skin involvement. What is the supply situation for 150 mg and 300 mg? Both 150 mg and 300 mg prefilled syringes and pens are available. The 300 mg pen combines two 150 mg doses in one device. When using older forms, patients must inject two 150 mg shots at each visit. When does the Cosentyx patent expire? Cosentyx patents are scheduled to expire in 2029. Biosimilars may appear around then or after any pediatric exclusivity extensions.
Other Questions About Cosentyx :